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The interplay of Hrd3 and the molecular 
chaperone system ensures efficient degradation 
of malfolded secretory proteins
Martin Mehnerta,*,†, Franziska Sommermeyera,*,‡, Maren Bergera, Sathish Kumar Lakshmipathya, 
Robert Gaussb, Markus Aebib, Ernst Jaroscha, and Thomas Sommera,c
aMax-Delbrück-Center for Molecular Medicine, 13125 Berlin, Germany; bInstitute of Microbiology, Department of 
Biology, Swiss Federal Institute of Technology Zurich, 8093 Zurich, Switzerland; cInstitute of Biology, Humboldt 
Universität zu Berlin, 10115 Berlin, Germany
ABSTRACT Misfolded proteins of the secretory pathway are extracted from the endoplasmic 
reticulum (ER), polyubiquitylated by a protein complex termed the Hmg-CoA reductase deg-
radation ligase (HRD-ligase), and degraded by cytosolic 26S proteasomes. This process is 
termed ER-associated protein degradation (ERAD). We previously showed that the mem-
brane protein Der1, which is a subunit of the HRD-ligase, is involved in the export of aberrant 
polypeptides from the ER. Unexpectedly, we also uncovered a close spatial proximity of Der1 
and the substrate receptor Hrd3 in the ER lumen. We report here on a mutant Hrd3KR that 
is selectively defective for ERAD of soluble proteins. Hrd3KR displays subtle structural chang-
es that affect its positioning toward Der1. Furthermore, increased quantities of the ER-resi-
dent Hsp70-type chaperone Kar2 and the Hsp40-type cochaperone Scj1 bind to Hrd3KR. Of 
note, deletion of SCJ1 impairs ERAD of model substrates and causes the accumulation of cli-
ent proteins at Hrd3. Our data imply a function of Scj1 in the removal of malfolded proteins 
from the receptor Hrd3, which facilitates their delivery to downstream-acting components 
like Der1.
INTRODUCTION
Protein folding in the endoplasmic reticulum (ER) is error-prone, and 
even in unstressed cells, a considerable fraction of the secretory pro-
teome will not attain its native conformation. Such defective con-
formers are selected by a protein quality control (PQC) system in the 
ER and dislocated into the cytoplasm, where they are decomposed 
by the ubiquitin proteasome system (Hirsch et al., 2009; Brodsky, 
2012; Ruggiano et al., 2014). This process is termed ER-associated 
protein degradation (ERAD). A key component of ERAD is the HMG-
CoA reductase degradation ligase (HRD-ligase). This multimeric ER 
membrane–embedded ubiquitin ligase was first identified in the 
yeast Saccharomyces cerevisiae but is conserved in all eukaryotic 
organisms. Hrd1, the central component of this assembly, is an-
chored in the ER membrane by six transmembrane segments and 
exposes a RING finger domain into the cytoplasm (Bays et al., 2001). 
Ubiquitylation of Hrd1 substrates is catalyzed by the ubiquitin-conju-
gating enzyme Ubc7, which is recruited to the ligase by its activating 
factor, Cue1 (Biederer et al., 1997; Bagola et al., 2013). An adaptor 
protein, Ubx2, brings the cytoplasmic Cdc48/Npl4/Ufd1 complex to 
the ligase, which targets ubiquitylated substrates from the ER to the 
proteasome (Neuber et al., 2005; Schuberth and Buchberger, 2005). 
Hrd1 forms oligomers upon binding to the scaffolding protein Usa1 
(Horn et al., 2009). In addition, Usa1 recruits the small membrane 
protein Der1, which participates in the dislocation of client proteins 
from the ER lumen into the cytoplasm (Carvalho et al., 2006; Horn 
et al., 2009, Mehnert et al., 2014). In the ER lumen, Hrd1 is associ-
ated with Hrd3, which in turn binds to the lectin Yos9 (Gardner et al., 
2000; Carvalho et al., 2006; Denic et al., 2006; Gauss et al., 2006a).
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by the program TPRpred, but other alignments have been discussed 
as well (Karpenahalli et al., 2007; Mittl and Schneider-Brachert, 
2007). Of note, the location of the most carboxy-terminal SLR in 
Hrd3 is essentially the same in all models. Sequential alignment of 
Hrd3 to homologues from other species identified a patch of several 
amino acid residues within the most carboxy-terminal SLR that are 
highly conserved (Figure 1A). To assess the importance of this re-
gion for Hrd3 function, we changed some of these residues to ala-
nine, leucine, and isoleucine, respectively, and monitored the effect 
of these mutants on ERAD. As determined in cycloheximide decay 
assays, the generated Hrd3 variants, with the exception of Hrd3 
E639A, are stable proteins (Figure 1B). Although Hrd1 becomes 
short-lived in the absence of its binding partner Hrd3, we did not 
observe Hrd1 degradation in any strain expressing the stable Hrd3 
variants, indicating that these proteins were correctly assembled 
with Hrd1. Pulse-chase analysis revealed that Hrd3 K652I/R653L 
(Hrd3KR) and Hrd3 N645I/R646I (Hrd3NR) displayed a significant 
defect in the turnover of the prevalent soluble ERAD substrate CPY* 
(Figure 1C). The other Hrd3 variants had only marginal effects on 
ERAD (Supplemental Figure S1A). Replacement of K652 and R653 
with alanine (Hrd3 K652A R653A) also substantially affected CPY* 
processing, which further underscores the relevance of these resi-
dues for Hrd3 function (Supplemental Figure S1B). A three-dimen-
sional structure prediction of Hrd3 generated by the Phyre2 homol-
ogy program (Kelley et al., 2009) with a confidence level of 100% 
revealed that SLRs in Hrd3 build a superhelix with the A-helices 
forming the inner concave surface (Supplemental Figure S1C). K652 
and R653 in the B-helix of the most carboxy-terminal SLR appear to 
be located at the surface, supporting a function of these residues in 
establishing protein–protein interactions. Intriguingly, the Hrd3KR 
mutant also blocked the turnover of another soluble ERAD sub-
strate, PrA*, whereas proteolysis of membrane-bound targets of the 
HRD-ligase, such as 6xMyc-Hmg2, and ectopically expressed CD4 
was not affected (Figure 1, D and E, and Supplemental Figure S1D). 
To investigate whether the degradation deficiency of Hrd3KR is spe-
cific for a certain type of misfolding or for the topology of a poly-
peptide, we analyzed the turnover of CT*, which is also a substrate 
of the HRD-ligase. CT* encompasses full-length CPY* fused to a 
transmembrane segment that anchors it in the ER membrane (Taxis 
et al., 2003). Unlike the degradation of CPY*, processing of CT* was 
not affected in Hrd3KR cells, which supports the notion that Hrd3KR 
is selectively defective for the turnover of soluble ERAD substrates 
and that the type of lesion on a target protein does not contribute 
to the mutant phenotype (Supplemental Figure S1E). Concordantly 
processing of KWW, a membrane-bound Hrd1 substrate that is de-
graded in a Der1-dependent manner (Vashist and Ng, 2004), was 
also not impaired in Hrd3KR cells (Supplemental Figure S1F). In 
summary, we created a Hrd3 mutant that allows the discrimination 
of Hrd3 function in the processing of soluble and membrane-bound 
client molecules. Furthermore, these results imply that particular 
parts in the luminal domain of Hrd3 are exclusively required for the 
targeting of soluble polypeptides to the HRD-ligase.
Hrd3KR binds increased amounts of chaperones
We next investigated the assembly of Hrd3KR into the ligase com-
plex. To this end, we immunoprecipitated hemagglutinin (HA) 
epitope–tagged variants of Hrd3 or Hrd3KR from cell lysates pre-
pared under nondenaturing conditions and analyzed the samples by 
immunoblotting. Of note, both HA-Hrd3KR and the wild-type protein 
precipitated equal amounts of the partner proteins Yos9 and Hrd1, as 
well as other of components of the HRD-ligase, like Usa1 and Ubx2 
(Figure 2A). Hrd3 forms oligomers in the ER (Horn et al., 2009), and 
The HRD-ligase targets structurally corrupted soluble proteins 
from the lumen as well as aberrant integral ER membrane proteins 
for proteolysis. However, it remains to be determined how this pro-
tein complex specifically identifies these highly diverse types of cli-
ent molecules and how it discriminates terminally misfolded poly-
peptides from species that are in the process of productive 
maturation. Genetic data imply that the Hrd3/Yos9 heterodimer is 
involved in this process (Denic et al., 2006; Gauss et al., 2006a; 
Izawa et al., 2012). The lectin Yos9 preferentially binds N-linked gly-
can structures on aberrant glycoproteins, which are most likely gen-
erated by the sequential action of the mannosidases Mns1 and 
Htm1 (Quan et al., 2008; Gauss et al., 2011). The activity of these 
enzymes is believed to destine unfolded proteins for ERAD and 
thereby delimitates the time a newly imported glycoprotein is given 
to attain its native conformation in the ER. Hrd3 exposes a large 
domain into the ER lumen containing numerous SEL1-like repeats 
(SLRs), which share a high degree of structural similarity with tetratri-
copeptide repeats (TPRs). TPRs and SLRs are believed to mediate 
protein–protein interactions (D’Andrea and Regan, 2003). Indeed, 
Hrd3 binds misfolded proteins in vivo (Gauss et al., 2006b). More-
over, the Hrd3/Yos9 unit was previously shown to interact with the 
ER-resident Hsp70-type chaperone Kar2—in mammals termed 
BiP—which proposes a close functional relation of these proteins 
(Denic et al., 2006). These findings support the idea that Hrd3 con-
stitutes the main substrate receptor of the HRD-ligase and that this 
protein selects client molecules by binding to malfolded regions. 
Yos9 refines the specificity of the receptor by identifying glycan moi-
eties, which are primarily found on glycoproteins that have already 
undergone futile folding attempts. Although this model sounds at-
tractive, the precise role of Hrd3 in substrate detection is unclear. In 
cells depleted of Hrd3, Hrd1 is rapidly degraded, thereby destruct-
ing the overall activity of the ligase (Gardner et al., 2000). This phe-
nomenon hampered a detailed analysis of Hrd3 function in vivo. 
Moreover, recent work identified regions within the transmembrane 
segments of Hrd1 that selectively contribute to the degradation of 
individual membrane-bound substrates, suggesting that they di-
rectly participate in the recognition of misfolded proteins (Sato 
et al., 2009). Therefore selection of some Hrd1 client molecules may 
not rely on Hrd3 function.
In this study, we report on a mutant variant Hrd3KR, which is 
specifically defective for the turnover of soluble ERAD substrates. 
Hrd3KR displays slight structural aberrations that affect its alignment 
to the downstream-acting protein Der1. We also find that Hrd3 as-
sociates with the ER-resident Hsp40-type cochaperone Scj1 and 
that the Hrd3KR variant binds larger quantities of this protein. In-
triguingly, deletion of SCJ1 blocks the degradation of ERAD sub-
strates and causes strong accumulation of such polypeptides at 
Hrd3. These observations imply that binding to Hrd3 initiates ERAD 
of soluble ER proteins and that Scj1 contributes to this process by 
promoting the release of polypeptides from Hrd3 and thereby en-
ables their delivery to downstream-acting factors like the dislocation 
apparatus.
RESULTS
Mutations in Hrd3 affect turnover of soluble clients
Yeast Hrd3 contains a large ER luminal domain predicted to contain 
six to nine SLRs. The SLR motif shares a highly similar α-helical archi-
tecture with tetratricopeptide repeats and is commonly believed to 
arrange protein–protein interactions (Ponting et al., 1999; D’Andrea 
and Regan, 2003). Owing to low sequence similarity, the accurate 
detection of individual SLRs in a protein sequence is difficult. We 
propose a positioning of the SLRs in Hrd3 according to a calculation 
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(Figure 2C). Thus it appears that the KR 
mutation causes an accumulation of CPY* 
directly at Hrd3. In addition, these results 
demonstrate that the enhanced substrate as-
sociation does not simply result from in-
creased steady-state levels of CPY* in Hrd3KR 
cells. In vitro experiments using purified Hrd3 
expressed in Sf9 insect cells provided further 
evidence for direct binding of this receptor 
to aberrantly folded protein structures. 
Chemically denatured luciferase aggregates 
upon dilution into aqueous buffer due to 
nonnative hydrophobic interactions. Progres-
sive clustering of luciferase increases the light 
scattering, which can be measured in a pho-
tometer. The addition of luminal domain of 
Hrd3 (Hrd3lum) to such an assay suppressed 
the aggregation of luciferase in a concentra-
tion-dependent manner to a similar extend 
as Escherichia coli–expressed DnaJ (Supple-
mental Figure S2A). Bovine serum albumin 
(BSA) did not impede luciferase agglomera-
tion. In contrast to a combination of DnaK, 
DnaJ, and GrpE, however, the addition of 
Hrd3lum failed to promote refolding of 
chemically denatured luciferase (Supplemen-
tal Figure S2B). These results indicated that 
Hrd3 prevented the aggregation of a dena-
tured protein by preserving it in an unfolded 
soluble state.
The KR mutation causes moderate 
structural changes in Hrd3
By employing site-specific in vivo photo-
cross-linking, we recently detected close 
spatial proximity of the membrane protein 
Der1 and the ER luminal exposed parts of 
Hrd3 (Mehnert et al., 2014). We used this 
approach to screen for alterations in Hrd3KR 
that would affect its activity in substrate 
processing. In short, plasmids encoding 
selected Myc epitope–tagged Der1 vari-
ants for the labeling with the photoactivat-
able cross-linker p-benzoyl-l-phenylalanine 
(pBpa) at a defined position were transformed into yeast cells 
expressing Hrd3 or Hrd3KR (Chen et al., 2007). After activation of 
the cross-linker by exposure to ultraviolet (UV) light, the cells were 
lysed under denaturing conditions, pBpa-Der1-Myc was immuno-
precipitated, and the samples were analyzed by immunoblotting. 
Of note, Hrd3 and Hrd3KR displayed subtle differences in the cross-
linking pattern to pBpa-labeled Der1. Most prominently, the inten-
sity of the Hrd3KR cross-link to position G38 and to a lesser extent 
also to position R33 in the ER-luminal loop 1 of Der1 was signifi-
cantly reduced (Figure 3, A and B). Conversely, the amount of the 
cross-linking product with position Q52 of Der1 appeared to be 
slightly increased in the Hrd3KR mutant (Figure 3B). These observa-
tions imply that the KR mutation causes moderate structural 
changes in Hrd3, which affect the spatial orientation of this protein 
toward Der1. Such small alterations may disturb the correct place-
ment of target molecules within the ligase complex and prevent 
efficient handover to downstream-acting components. Indeed, 
we were unable to detect significant deviations in the cross-linking 
we wondered whether the KR mutation affects this feature. Therefore 
we expressed combinations of HA-tagged variants of Hrd3 or Hrd3KR 
along with untagged versions in yeast cells and precipitated the HA-
Hrd3 proteins. We were able to detect equal amounts of untagged 
Hrd3 in all precipitates, indicating that the KR mutation did not affect 
oligomerization of this protein (Figure 2B). Intriguingly, we copurified 
increasing amounts of the ER-resident Hsp70-type chaperone Kar2 
and the Hsp40- type cochaperone Scj1 with HA-Hrd3KR (Figure 2A). 
Even more striking, we also detected significantly more of the sub-
strate CPY* in the HA-Hrd3KR precipitate. To figure out whether the 
KR mutation leads to a general enrichment of CPY* at the HRD-ligase, 
we monitored the association of this substrate with the downstream-
acting components Der1 and Hrd1 in Hrd3KR- expressing cells by 
immunoprecipitation. We expected to preferentially detect direct 
binding of these proteins to client molecules due to the relatively 
weak and transient nature of such interactions. Indeed, in precipitates 
of Der1-Myc or Hrd1-HA from extracts of cells expressing either Hrd3 
or Hrd3KR, the amount of copurified CPY* was virtually the same 
FIGURE 1: Conserved residues are important for Hrd3 function. (A) Schematic drawing of the 
Hrd3 protein (top). Positions of the signal sequence (green), the transmembrane segment (blue), 
and the predicted nine SEL1-like repeats (orange) according to a calculation by TPRpred 
(Karpenahalli et al., 2007). Bottom, ClustalW2 (McWilliam et al., 2013) alignment of the most 
carboxy-terminal SLR of Hrd3 from S. cerevisiae (Q05787), and its homologues from Candida 
glabrata (Q6FNV5), Caenorhabditis elegans (CAB01505), Mus musculus (NP_001034178), and 
Homo sapiens (NP_005056). Conserved residues are shaded black. Predicted secondary 
structure elements are shown at the top of the sequences (helices A and B). (B) Stability of Hrd3 
variants mutated for the given residues and Hrd1 in these strains as determined in a 
cycloheximide decay assay. The mutated Hrd3 versions were expressed from a plasmid in a 
yeast strain deleted for endogenous HRD3. Sec61 served as a loading control. (C–E) Pulse-chase 
analysis to monitor the turnover of CPY*, PrA*, and 6xMyc-Hmg2. The given Hrd3 variants were 
expressed from either the corresponding genomic locus (C, D) or from low-copy-number 
plasmids in cells disrupted for endogenous HRD3 (∆hrd3) (E). Quantification of three 
independent experiments with SD of the mean.
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bound Scj1, as well as of Kar2, was considerably increased in the 
Hrd3KR mutant. Therefore we set out to investigate any involve-
ment of Scj1 in ERAD. As determined by pulse-chase analysis, the 
deletion of SCJ1 but not of JEM1 or ERJ5 strongly affected CPY* 
turnover (Figure 4A). Similarly, cells lacking Scj1 but not Jem1 were 
impaired for PrA* degradation (Figure 4B). In contrast, processing of 
the membrane-bound substrates 6xMyc-Hmg2 and KWW was 
barely delayed in the absence of Scj1 (Figure 4C and Supplemental 
Figure 1F). Deletion of SCJ1 may affect the assembly of the HRD-li-
gase and thereby interfere with its activity toward selected ERAD 
substrates. Therefore we precipitated HA-Hrd3 or HA-Hrd3KR from 
extracts of either wild-type or ∆scj1 cells under nondenaturing con-
ditions. We detected equal amounts of Yos9, Hrd1, and Ubx2 in the 
precipitates, suggesting a correct integration of Hrd3 into the HRD-
ligase in both strains (Figure 4D). However, the amount of Kar2 was 
considerably increased in the HA-Hrd3 precipitates of SCJ1-deleted 
cells.
Substrate accumulates at Hrd3 in the absence of Scj1
Scj1 could assist the identification of malfolded proteins and thus be 
involved in the recruitment of client molecules by Hrd3. We there-
fore investigated the effect of Scj1 on CPY* processing by precipi-
tating HA-Hrd3 from lysates of cells lacking either Jem1 or Scj1 and 
recorded the amount of bound CPY* by immunoblotting. Strikingly, 
deletion of SCJ1 but not of JEM1 resulted in extensive accumula-
tion of the ERAD substrate CPY* at Hrd3 (Figure 5A). This effect was 
not enhanced in Hrd3KR cells, indicating that Scj1 and Hrd3 func-
tion in the same pathway for CPY* processing (Figure 5B). In line 
with this, we observed that CPY* turnover was impaired to a similar 
extent in cells expressing Hrd3KR, deleted for SCJ1, or harboring 
both the Hrd3KR and ∆scj1 mutations (Figure 5C). Strong overex-
pression of CPY* caused only a very moderate increase in the 
amount of Scj1 that was copurified with HA-Hrd3, although substan-
tially more substrate was detected in the precipitate (Figure 5D). 
This finding strongly suggests that the association of Scj1 (and pos-
sibly also of Kar2) with Hrd3 is not indirectly mediated via the bind-
ing of either factor to client molecules. Instead, Scj1 and Hrd3 inter-
act in a substrate-independent manner.
We also wanted to determine the site of substrate accumulation 
on Hrd3 in the absence of Scj1 in more detail. To this end, we per-
formed in vivo cross-linking with pBpa-labeled Der1 variants in ei-
ther wild-type or ∆scj1 cells and analyzed these reactions for the 
amount of the cross-linked substrate CPY*-HA. Of note, we de-
tected significantly more pBpa-Der1/CPY* cross-linking products for 
positions in the Der1 luminal loop 1 than for membrane-embedded 
parts in strains lacking Scj1 when compared with wild-type cells 
(Figure 6A). This observation demonstrates that in the absence of 
Scj1, ERAD substrates arrest at Hrd3 in close proximity to the ER 
luminally exposed parts of Der1. Of importance, this result also im-
plies that substrate accumulation in Hrd3KR and ∆scj1 strains occurs 
at different sites at the HRD-ligase (compare cross-linking patterns 
in Figures 3C and 6A). Consequently the overexpression of Scj1 in 
Hrd3KR cells was unable to trigger the release of client molecules 
from the mutated receptor as determined in immunoprecipitation 
experiments (Figure 6B) and failed to rescue the ERAD defect ob-
served in such yeast strains (Figure 6C).
DISCUSSION
Terminally misfolded proteins of the secretory pathway are effi-
ciently cleared from the ER by the membrane-bound HRD-ligase 
complex. In this study, we provide evidence for a function of Hrd3 as 
the major substrate receptor for soluble ER luminal client proteins of 
pattern of pBpa-Der1 to CPY* compared with the wild-type strain, 
indicating that this substrate does not accumulate at the Hrd3-Der1 
interface in the Hrd3KR mutant (Figure 3C).
The Hsp40-type cochaperone Scj1 is required for ERAD
Previous studies based on genetic experiments suggested a func-
tion of the ER-resident Hsp70-type chaperone Kar2 in conjunction 
with the Hsp40 type cochaperones Scj1 and Jem1 in the disposal of 
ERAD substrates (Nishikawa et al., 2001; Buck et al., 2010). Hsp40 
type proteins contain a so-called DnaJ domain and control substrate 
processing of Hsp70 chaperones by regulating their ATP hydrolysis 
(Kampinga and Craig, 2010). In addition to Scj1 and Jem1, Erj5 and 
Sec63 also belong to the group of Hsp40-type proteins that reside 
in the yeast ER. Sec63 is an essential component of the translocation 
machinery that promotes the import of proteins from the cytoplasm 
into the ER (Park and Rapoport, 2012). Mutants in SEC63 display 
pleiotropic phenotypes caused by a general impairment to maintain 
ER homeostasis. To avoid indirect effects generated by the ambigu-
ous nature of these phenotypes, we did not further investigate a 
role of Sec63 in ERAD. Cells lacking Scj1, Jem1, or Erj5 are viable, 
and the detailed molecular function of these proteins in ER protein 
maturation is still elusive (Nishikawa et al., 2001; Carla Fama et al., 
2007; Buck et al., 2010). In immunoprecipitation experiments, we 
found a previously unnoticed interaction of Hrd3 with the Hsp40-
type cochaperone Scj1 (Figure 2A). Intriguingly, the amount of 
FIGURE 2: Hrd3KR is fully integrated into the HRD-ligase. 
(A) Microsomes prepared from ∆hrd3 cells expressing plasmid-
encoded HA-Hrd3 or HA-Hrd3KR were solubilized with NP40, and the 
Hrd3 variants were precipitated with anti-HA antibodies under 
nondenaturing conditions. The bound proteins were analyzed by 
SDS–PAGE and immunoblotting using the indicated antibodies. 
(B) HA-tagged Hrd3 variants were precipitated from lysates of yeast 
cells expressing HA-Hrd3 or HA-Hrd3KR and containing plasmids 
encoding Hrd3 or Hrd3KR under nondenaturing conditions. The 
precipitates were analyzed by immunoblotting with the given 
antibodies. (C) Plasmid-borne Hrd3 or Hrd3KR were expressed in 
∆hrd3 Der1-Myc (left) or ∆hrd3 Hrd1-HA (right) cells. Der1-Myc and 
Hrd1-HA were then purified from solubilized microsomal preparations 
and the precipitates analyzed by immunoblotting with the indicated 
antibodies.
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receptor, which is a prerequisite for their proper processing by the 
HRD-ligase. In this way, Scj1 probably regulates the association of 
substrate–chaperone complexes with Hrd3.
Although speculative at the moment, we propose the following 
model for the functional interplay of Hrd3 and Scj1 in ERAD (Figure 
7). The association of a misfolded luminal polypeptide with Hrd3 initi-
ates its degradation. It remains to be determined whether aberrant 
proteins directly bind to this receptor. Such a scenario is supported 
by our in vitro assays. Alternatively, Hrd3 may recognize specific 
assemblies containing malfolded polypeptides in complex with 
molecular chaperones. Next Scj1, probably in conjunction with the 
Hsp70-type chaperone Kar2, will promote the release of bound sub-
strates from the Hrd3 receptor. The accumulation of Kar2, Scj1, and 
substrate at the Hrd3KR mutant suggests that the activity of Scj1 may 
be enhanced toward Hsp70–substrate complexes when they are pre-
sented by Hrd3 in a defined manner. Detachment of a client mole-
cule from Hrd3 most likely does not immediately direct it to ERAD 
but allows its escape into the lumen for repeated folding attempts as 
well. However, the engagement of a polypeptide with Hrd3 will bring 
it into close spatial proximity to the membrane protein Der1. This 
small subunit of the HRD-ligase was recently shown to facilitate mem-
brane insertion of ERAD substrates, which triggers their dislocation 
into the cytoplasm (Mehnert et al., 2014). As such, Der1 displays a 
weak affinity for malfolded proteins, which might suffice to take over 
substrates detached from Hrd3 (Gauss et al., 2006b; Mehnert et al., 
2014). We would expect that the efficient transfer of cargo from Hrd3 
to Der1 relies on a tight spatial organization of both proteins within 
the HRD-ligase. Indeed, we previously observed such a close ar-
rangement in in vivo cross-linking experiments (Mehnert et al., 2014). 
Concordantly our data imply that the correct alignment of Hrd3 and 
Der1 is critical for substrate processing because the Hrd3KR mutant, 
which displays moderate aberrations in its orientation toward Der1, is 
this ligase. A mutation in the most carboxy-terminal SLR of Hrd3 
termed Hrd3KR causes a specific defect in the ligase complex to 
process soluble client molecules. Of interest, the KR mutation is lo-
cated in a region of Hrd3 that was implicated to mediate the interac-
tion to its partner Hrd1 (Gauss et al., 2006b). Moreover, this part of 
the mammalian Hrd3 homologue Sel1L is required to suppress pro-
liferation in tumor growth (Cattaneo et al., 2004). We were not able 
to detect major rearrangements within the HRD-ligase in cells ex-
pressing Hrd3KR. However, we observed slight structural changes 
that seem to affect proper alignment of Hrd3KR to other subunits of 
this complex and thereby most likely impede the transfer of bound 
client molecules to downstream-acting factors. We also noticed a 
significant accumulation of substrate at the Hrd3KR protein, indicat-
ing that the efficient detachment of clients may also depend on the 
correct orientation of Hrd3 to other factors of the HRD-ligase. In-
deed, substrate molecules do not accumulate at the Hrd3-Der1 in-
terface in this mutant. Strikingly, we also detected an association of 
Hrd3 with the Hsp40-type cochaperone Scj1. This observation im-
plied a previously unnoticed functional interplay of Hrd3 and the 
molecular protein-folding machinery of the ER. Hsp40-type proteins 
regulate ATP hydrolysis of Hsp70-type chaperones via their DnaJ 
domain and thereby modulate substrate processing by these en-
zymes (Kampinga and Craig, 2010). Deletion of SCJ1 impaired turn-
over of soluble ERAD substrates but had little effect on the degrada-
tion of a membrane-bound one. Along with the finding that the 
combination of the Hrd3KR mutation with a deletion of SCJ1 had no 
additive effect on CPY* turnover, this observation implies that both 
proteins act in the same pathway of ERAD. Because we observed 
substantially increased amounts of client molecules and Kar2 associ-
ated with Hrd3 in cells depleted for Scj1, we do not assume a func-
tion of this cochaperone in substrate recruitment. Instead, Scj1 ap-
pears to participate in the release of polypeptides from the Hrd3 
FIGURE 3: Hrd3KR displays subtle structural alterations. (A) Yeast cells expressing endogenous Hrd3 or Hrd3KR were 
transformed with high-copy plasmids derived from pMM075 encoding Der1-Myc variants controlled by the CUP1 
promoter that each contained an amber stop codon at the indicated positions (Mehnert et al., 2014). The expression of 
a suppressor tRNA and a corresponding tRNA synthetase allows the incorporation of the photoreactive amino acid 
analogue pBpa at these sites (Chen et al., 2007). Where indicated, cells were irradiated with UV light, followed by cell 
lysis and immunoprecipitation of Der1-Myc under denaturing conditions. The precipitates were analyzed by SDS–PAGE 
and immunoblotting. Labeling with pBpa was carried out for positions in the first luminal loop of Der1. (B) Same as in A, 
but Der1-Myc was labeled with pBpa at positions in the first (R33) or the second transmembrane domain (D62) or the 
first luminal loop (Q52). (C) Cells expressing HA-tagged CPY* and Hrd3 or Hrd3KR were transformed with Der1-Myc 
construct for the incorporation of pBpa at positions in the first luminal loop (G38 and Y44) or in the second 
transmembrane domain (S70). The experiment was analyzed as in A.
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et al., 2008; Ushioda et al., 2008). Of inter-
est, this protein contains a DnaJ domain and 
binds to the Hsp70-type chaperone BiP as 
well as to the Hrd3 homologue Sel1L 
(Ushioda et al., 2013; Williams et al., 2013). 
Similar to yeast Scj1, ERdj5 could therefore 
promote dissociation of cargo from BiP and 
Sel1L and thereby facilitate its processing by 
downstream-acting factors of the ERAD 
pathway. Thus the folding machinery of the 
ER may contribute to the degradation of ab-
errant proteins in several ways. On one 
hand, components of the ER-PQC partici-
pate in the identification of malfolded poly-
peptides. Selection of defective proteins 
possibly involves the prolonged association 
of such conformers with folding enzymes 
and their subsequent delivery to the recep-
tors of the ERAD ubiquitin ligases. Quite 
unexpectedly, particular elements of the ER-
PQC also facilitate the release of malfolded 
polypeptides from the receptors, which 
stimulates the routing of such species to the 
dislocation apparatus and thereby supports 
the dynamics of substrate processing in the 
course of ERAD.
MATERIALS AND METHODS
Antibodies
Monoclonal anti-HA (HA-7) and anti-Myc 
(9E10) antibodies (Sigma-Aldrich, St. Louis, 
MO), monoclonal and polyclonal anti-CPY 
antibodies (Abcam, Cambridge, UK), and 
polyclonal antiserum directed against CD4 
(Santa Cruz Biotechnology, Dallas, TX) are commercially available. 
Polyclonal anti–proteinase A antiserum was kindly provided by Di-
eter H. Wolf (University of Stuttgart, Stuttgart, Germany). Polyclonal 
antibodies specific for Hrd3, Hrd1, Sec61, Kar2, Yos9, Ubx2, and 
Usa1 were raised in rabbits by immunization with affinity-purified 
proteins expressed in E. coli.
Yeast strains
All S. cerevisiae strains used in this study were haploid descendants 
of DF5, and their genotypes are given in Supplemental Table S1. 
Standard protocols were followed for the preparation of media and 
the transformation of cells by the lithium acetate method. PCR-
based techniques were used to construct strains expressing C-ter-
minally or internally epitope-tagged variants of Hrd3, Jem1, and 
Scj1 from their chromosomal locus under control of their native pro-
moter (Longtine et al., 1998; Knop et al., 1999).
Plasmids
Plasmids used in this study are listed in the Supplemental Table S2. 
CT* and KWW were expressed from plasmids pWO804 (Taxis et al., 
2003) and pSM101 (Vashist and Ng, 2004), respectively. The PrA* 
expression vector pTX339 was constructed by ligating NotI-XhoI 
fragments released from plasmid pES163 (Spear and Ng, 2005) into 
the NotI-XhoI sites of yeast vector pRS415. CD4 was heterologously 
expressed in yeast from plasmid pBM108 (Meusser and Sommer, 
2004). HRD3-expressing plasmids were generated by PCR amplifi-
cation of the open reading frame from genomic DNA using the 
primers FZ81 5′ attggtaccTGATGTAGAGCAGTAACTGGAAG and 
impaired in ERAD. In summary, we suggest that the selection of 
ERAD substrates involves the reiterated interaction with and Scj1-
stimulated release from Hrd3, which will increase the probability of a 
polypeptide to interact with Der1 and subsequently to be routed for 
degradation by the ERAD machinery.
This scenario shows functional parallels to the posttranslational 
import of proteins into mitochondria. Here substrate molecules 
containing internal targeting sequences associate with cytoplasmic 
Hsp70s. This complex specifically binds to the TPR motifs present in 
the outer membrane receptors Tom70 and 71 (Young et al., 2003). 
Remarkably, Tom70 and 71 share a similar structural organization 
with Hrd3: they are anchored to the membrane by a single trans-
membrane segment and expose a large domain containing TPRs or 
the highly related SLRs toward the site of substrate recruitment. Cli-
ent molecules bound to Tom70/71 are then handed over to the 
general substrate receptors of the outer membrane Tom20/Tom22 
and subsequently inserted into the mitochondrial membranes (Baker 
et al., 2007; Kutik et al., 2007). Not much is known on how substrate 
proteins are detached from Tom70/71 and how they are transferred 
to downstream-acting components. The regulated release of cargo 
by the activity of Hsp40 cofactors may trigger this process. Intrigu-
ingly, the yeast DnaJ-like protein Djp1 was shown to be required for 
Tom70-dependent mitochondrial protein import (Papic et al., 2013). 
In addition, in mammals, various cytoplasmic Hsp40-type proteins 
participate in mitochondrial protein import; however, their contribu-
tion to this process remains unclear (Bhangoo et al., 2007).
In mammalian cells, the protein disulfide isomerase ERdj5 is re-
quired for the turnover of aberrant secretory polypeptides (Dong 
FIGURE 4: Scj1 is required for ERAD. (A–C) Quantification of radioactive pulse-chase analysis 
to monitor the degradation of CPY* (A), PrA* (B), or 6xMyc-Hmg2 (C) in strains of the given 
genotype. Mean values of three (A) or two (B, C) experiments. (D) HA-Hrd3 or HA-Hrd3KR 
expressed from the chromosomal locus were immunoprecipitated from lysates of yeast strains 
of the indicated genotypes. The precipitates were analyzed by immunoblotting using the given 
antibodies.
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FIGURE 5: Accumulation of substrate at Hrd3 in cells lacking 
Scj1. (A) HA-Hrd3 expressed from the chromosomal locus was 
purified from lysates of yeast cells of the given genotype and 
the precipitates analyzed by immunoblotting. (B) HA-Hrd3 or 
HA-Hrd3KR expressed from plasmids in cells deleted for hrd3 
was purified from lysates prepared under nondenaturing 
conditions and the precipitates analyzed by immunoblotting 
with the given antibodies. (C) Pulse- chase experiment to 
determine the degradation of CPY* in yeast cells of the indicated 
genotype. Mean values of three independent experiments with 
SD of the mean. (D) Lysates were prepared from cells lacking Hrd3 
and containing plasmids for the expression of Hrd3 or Hrd3KR. 
The HA-tagged Hrd3 variants were then immunoprecipitated 
and the precipitates analyzed by immunoblotting. Where 
indicated, CPY* was overexpressed using a multi-copy-number 
plasmid.
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FZ80 5′ tatgagctcGTATCACCTTCGCCAATGC and cloned into 
vector pRS317, thereby generating plasmid pJU301, or into pRS316, 
generating plasmid pFZ063. HRD3 mutants were generated using 
the QuikChange Site-Directed Mutagenesis kit (Stratagene, Santa 
Clara, CA), generating plasmid pFZ29 when using pJU301 as a tem-
plate or pFZ064 using pFZ063. Plasmid pRH244 (Hampton et al., 
1996) was used to introduce 6xMyc-Hmg2 into yeast strains.
Immunoprecipitations
Logarithmically growing cells were collected and washed with water 
supplemented with 1 mM phenylmethylsulfonyl fluoride (PMSF). We 
disrupted 100 OD600 of cells with glass beads in 400 μl of ice-cold 
IP-32 buffer (50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid [HEPES]–NaOH, pH 7.2, 50 mM NaCl, 125 mM KOAc, 2 mM 
MgAc2, 1 mM EDTA, 10 μM CaCl2, 3% glycerol, 1 mM PMSF, 
pH 7.5). We added 1.2 ml of IP-32 buffer and removed cellular de-
bris by centrifugation at 1000 × g for 5 min at 4°C. Microsomes were 
collected by centrifugation at 20,000 × g for 20 min at 4°C and solu-
bilized in 1.2 ml of IP-32 lysis buffer (IP-32 supplemented with 0.5% 
NP-40). Lysates were cleared by centrifugation at 20,000 × g for 
10 min at 4°C, and epitope-tagged proteins were precipitated with 
anti-HA or anti-Myc antibodies coupled to protein A Sepharose 
beads (Amersham, Pittsburgh, PA) at 4°C overnight. Beads were 
washed three times with 1 ml of IP-32 lysis buffer, and bound pro-
teins were eluted with SDS sample buffer before analysis by SDS–
PAGE and immunoblotting.
Pulse-chase analysis
Pulse-chase experiments were performed as described (Gauss 
et al., 2006b). Cells were pulse labeled with 35S-radiolabeled me-
thionine and cysteine (Perkin Elmer, Waltham, MA) and chased 
into medium containing unlabeled amino acids. Samples were 
taken at the indicated time points and lysed, and the protein of 
interest was precipitated using specific antibodies. CPY*- and 
PrA*-containing precipitates were treated with endoglycosidase F 
(Roche, Basel, Switzerland). Samples were then separated by SDS–
PAGE. Quantification of the signals was done on a Typhoon 
LFA9500 laser scanner (GE Healthcare, Buckinghamshire, UK) 
using the Image Quant software.
Cycloheximide decay assay
A detailed description can be found in Meusser et al. (2004). Loga-
rithmically growing cells were diluted into fresh medium, and pro-
tein synthesis was inhibited by addition of cycloheximide to a con-
centration of 1 mg/ml. Aliquots were taken at indicated time points. 
Cells were lysed, and the proteins were analyzed by SDS–PAGE and 
immunoblotting. The signals were quantified using Cy5-labeled 
secondary antibodies (Life Technologies) and a Typhoon FLA9500 
laser scanner employing the Image Quant software.
Site-specific in vivo photo-cross-linking
Yeast cells were transformed with plasmid pGK1-pBpa encoding a 
suppressor tRNA and the corresponding tRNA synthetase (Chen 
et al., 2007). In addition, the yeast cells expressed plasmid-encoded 
Der1-Myc constructs containing an amber stop codon at defined 
positions (derived from pMM075). For the incorporation of the 
cross-linker, yeast cells were grown in synthetic medium supple-
mented with 0.4 mM photoreactive amino acid analogue pBpa 
overnight. Expression of the pBpa-labeled Der1-Myc constructs was 
induced by the addition of 1 mM CuSO4 for 2 h. Activation of the 
cross-linker occurred by UV irradiation at λ = 365 nm for 45 min on 
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ice (B-100AP; UVP, Upland, CA). After cell lysis and removal of the 
debris by centrifugation, Der1-Myc was immunoprecipitated with 
anti-Myc antibodies. The cross-linking products were eluted from 
the beads with dithiothreitol (DTT)-containing sample buffer and 
analyzed by SDS–PAGE, followed by immunodetection using spe-
cific antibodies. A detailed description of the cross-linking proce-
dure can be found elsewhere (Mehnert et al., 2014).
Purification of Hrd3
The coding sequence of the luminal domain of Hrd3 (residues 
21–768) was cloned in pFastBac 1 vector (Invitrogen, Carlsbad, CA) 
FIGURE 7: Proposed model for the orchestrated function of Scj1 and 
Hrd3 in ERAD. Unfolded proteins (red), possibly in complex with 
molecular chaperones like Kar2, bind to Hrd3. The DnaJ-like protein 
Scj1 stimulates the dissociation of this transient assembly, which 
causes the detachment of the client protein and Kar2 from Hrd3. The 
unfolded polypeptide may then be released into the ER lumen, where 
it will again engage components of the folding machinery (refolding). 
Alternatively, it may get in contact with Der1, which resides in close 
spatial proximity to Hrd3. Der1 displays a weak affinity for aberrantly 
folded proteins, which might suffice to take over cargo released from 
Hrd3. At the same time, Der1 facilitates insertion of malfolded 
proteins into a dislocation apparatus, which will direct these 
polypeptides for ubiquitylation by Hrd1 and degradation by 
cytoplasmic proteasomes (ERAD). In the absence of Scj1 (∆scj1), the 
detachment of substrate from Hrd3 is impaired, which results in the 
accumulation of malfolded substrates at the Hrd3/Der1 interface. 
Conversely, the KR mutation causes a structural rearrangement in 
Hrd3 that blocks the efficient transfer of substrate molecules to Der1 
and their dislocation into the cytoplasm.
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FIGURE 6: The deletion of Scj1 causes substrate accumulation at the 
Hrd3-Der1 interface. (A) Site-specific in vivo photo-cross-linking of 
Der1-Myc to CPY*-HA in cells of the given genotype. Plasmid-
encoded Der1-Myc labeled with pBpa at positions in the first luminal 
loop (G38 and Y44) or in the second transmembrane domain (S70) 
was immunoprecipitated from cell lysates after UV irradiation using 
anti-Myc antibodies. The precipitates were analyzed by 
immunoblotting with the indicated antibodies. (B) ∆hrd3 ∆scj1 cells 
were transformed with plasmids encoding HA-Hrd3, HA-Hrd3KR, and 
constructs that express 1xHis-Scj1 from a low- copy-number vector 
(His-Scj1, pMM100) or a high-copy-number vector (His-Scj1 OE, 
pMM101). HA-tagged Hrd3 was immunoprecipitated, and the 
samples were analyzed by immunoblotting. His-Scj1 could not be 
detected in the precipitate due to strong cross-reactions with the 
precipitating antibodies. (C) Scj1 was overexpressed in yeast cells of 
the given genotype, and the degradation of CPY* was monitored 
in radioactive pulse chase experiments. Mean values of three 
independent experiments.
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under the Polyhedrin promoter (pRG69). Recombinant baculoviral 
stock was generated from Sf9 insect cells according to the manufac-
turer’s instructions. For protein expression, 30 ml of baculovirus was 
added to 3 l Sf9 cells in Sf-900 II SFM medium (Invitrogen) at a den-
sity of 2 million cells/ml and expression carried out for 48 h. Cells 
were pelleted, washed once with phosphate-buffered saline (PBS), 
and suspended in PBS supplemented with 1 mM DTT, 1 mM PMSF, 
5 μM E64, and 0.5% Nonidet P40. Cells were lysed in a Dounce 
homogenizer and incubated for 2 h at 4°C. The lysate was cleared 
at 100,000 × g for 1 h at 4°C and loaded onto glutathione Sepharose 
4 fast flow equilibrated in the same buffer. After overnight binding 
at 4°C and washing of the beads, Prescission protease was added 
and the beads incubated for 6 h in the cold room. The cleaved 
Hrd3lum protein in the supernatant was recovered and concen-
trated in an Ultracel centrifugal filter (Millipore, Billerica, MA), and 
the final protein concentration was determined by the Lowry 
method.
Light scattering experiments
Firefly luciferase was denatured in 6 M GdmHCl for 30 min at 25°C. 
The denatured protein was diluted into refolding buffer (20 mM 
HEPES-KOH, pH 7.5, 50 mM KCl, 2 mM MgCl2) to a final concentra-
tion of 100 nM in the presence of indicated concentrations of 
proteins in a fluorescence cuvette. Light scattering at 350 nm was 
recorded in a Fluoromax 4 fluorimeter (GE Healthcare) at 25°C in a 
time course.
Luciferase activity measurements
Chemically denatured firefly luciferase (luc) was diluted in refolding 
buffer (50 mm HEPES, pH 7.65, 120 mm KCl, 10 mm MgCl2,), 3 mM 
ATP, 10 mg/ml BSA, and 5 mM DTT to a final concentration of 
100 nM. Where indicated, 5 μM DnaK, 1 μM DnaJ, 3 μM GrpE (kind 
gifts from Bernd Bukau, University of Heidelberg, Heidelberg, 
Germany), or 200 nM Hrd3 was added. After a short incubation, the 
reactions were stopped in 25 mM Tris-phosphate, 2 mM DTT, 2 mM 
EDTA, 10% glycerol, 1% Triton X-100, and 1 mg/ml BSA, and the 
enzymatic activity was determined in a Lumat LB 9507 luminometer 
(Berthold Technologies, Midland, ON, Canada) in the presence of 
Luciferase assay buffer (Promega, Madison, WI) according to the 
manufacturer’s protocol.
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Supplementary Figure legends 
 
Supplementary Figure S1. (A) Yeast cells disrupted for hrd3 and expressing the indicated 
plasmid-encoded Hrd3 variants were monitored for CPY* degradation by pulse chase 
analysis. (B) Turnover of CPY* was determined in ∆hrd3 yeast strains containing empty 
vector or plasmids for the expression of Hrd3KR or Hrd3 K652A R653A by radioactive pulse 
chase analysis. Mean values of two independent experiments are shown. (C) Predicted 
structural model of Hrd3 as calculated by the Phyre2 program (Kelley and Sternberg, 2009). 
The insert depicts the relative position of residues K652 and R653 in the most 
carboxyterminal SLR. (D) Cycloheximide decay experiment to measure CD4 turnover in 
∆hrd3 cells containing plasmids for the expression of the indicated Hrd3 variants. Signals 
from the fluorescently-labeled secondary antibodies were quantified using a laser scanner. 
Mean values of two independent experiments are shown. (E) Radioactive pulse-chase 
analysis to investigate the degradation of plasmid-encoded CT* in yeast cells of the given 
genotype. (F) Pulse chase analysis of KWW-turnover in cells of the indicated genotype. Two 
independent experiments were quantified and mean values representing the percent of 
KWW left at the specified time points are given in the bottom line. 
 
Supplementary Figure S2. (A) Hrd3 prevents aggregation of a malfolded protein in vitro. 
The ER-luminal part of Hrd3 (Hrd3lum) expressed in insect cells was purified and added in 
the given molar ratio to chemically denatured firefly luciferase (Luc) that was diluted in buffer. 
Aggregation of luciferase was measured in a time course by light scattering at 350 nm. Units 
on the x-axis refer to light absorption of the sample. Buffer (), BSA () and DnaJ purified 
from E.coli (; kindly provided by J. Brodsky) served as controls. (B) Chemically denatured 
firefly luciferase was incubated in refolding buffer (Promega) containing the indicated 
proteins. The enzymatic activity was determined in a luminometer according to the 
manufacturer’s protocol. Mean values from three independent experiments in percent activity 
of the non-denatured protein (native) and standard deviation of mean are given.  
 
 
Supplementary Figure S1; Mehnert et al.
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Supplementary Table 1 
Name Genotype Resource 
YBM70 ∆hrd3::LEU2, prc1-1, trp1-1(am), his3- 200, ura3-52, lys2-801, leu2-3,-
112, MATa 
Meusser et al., 
2004 
YCH232 6xHA-HRD3, YOS9-myc7xHIS(kanMX6), prc1-1, trp1-1 (am), his3- 
200, leu2-3,-112, lys2-801, ura3-52, MATa 
Gauss et al., 
2006b 
YFZ004 6xHA-hrd3(M637V), prc1-1, trp1-1 (am), his3- 200,  leu2-3,-112, lys2-
801, ura3-52, MATa 
this work 
YFZ005 6xHA-hrd3(H638L), YOS9-myc7xHIS(kanMX6), prc1-1, trp1-1 (am), 
his3- 200,  leu2-3,-112, lys2-801, ura3-52, MATa 
this work 
YFZ006 6xHA-hrd3(M637V), YOS9-myc7xHIS(kanMX6), prc1-1, trp1-1 (am), 
his3- 200,  leu2-3,-112, lys2-801, ura3-52, MATa 
this work 
YFZ007 6xHA-hrd3(KL(675/676)IV), YOS9-myc7xHIS(kanMX6), prc1-1, trp1-1 
(am), his3- 200, leu2-3,-112, lys2-801, ura3-52, MATa 
this work 
YFZ008 6xHA-hrd3(E639A), YOS9-myc7xHIS(kanMX6), prc1-1, trp1-1 (am), 
his3- 200,  leu2-3,-112, lys2-801, ura3-52, MATa 
this work 
YFZ015 URA3::6xmyc-Hmg2, ∆hrd3::LEU2, ∆prc1::LEU2, prc1-1, trp1-1(am), 
his3- 200, ura3-52, lys2-801, leu2-3,-112, MATa 
this work 
YFZ022 ∆pra1::TRP1, prc1-1, trp1-1(am), his3- 200, ura3-52, lys2-801, leu2-3,-
112, MATa 
this work 
YFZ023 ∆pra1::TRP1, ∆hrd3::LEU2, prc1-1, trp1-1(am), his3- 200, ura3-52, 
lys2-801, leu2-3,-112, MATa 
this work 
YFZ024 ∆pra1::TRP1, 6xHA-Hrd3, YOS9-myc7xHIS(kanMX6), prc1-1, trp1-
1(am), his3- 200, ura3-52, lys2-801, leu2-3,-112, MATa 
this work 
YFZ025 ∆pra1::TRP1, 6xHA-Hrd3 KR652/653IL, YOS9-myc7xHIS(kanMX6), 
prc1-1, trp1-1(am), his3- 200, ura3-52, lys2-801, leu2-3,-112, MATa 
this work 
YFZ028 ∆pra1::TRP1, ∆scj1::HIS3, prc1-1, trp1-1(am), his3- 200, ura3-52, 
lys2-801, leu2-3,-112, MATa 
this work 
YFZ044 ∆hrd3::LEU2, ∆scj1::HIS3, prc1-1, trp1-1(am), his3- 200, ura3-52, lys2-
801, leu2-3,-112, MATa 
this work 
YRG020 6xHA-HRD3, prc1-1, trp1-1(am), his3- 200, leu2-3,-112, lys2-801, 
ura3-52, MATa 
Gauss et al., 
2006b 
YRG146 SCJ1-9xMyc (TRP1), prc1-1, trp1-1(am), his3-∆200, ura3-52, lys2-
801, leu2-3,-112, MATalpha 
this work 
YRG175 6xHA-HRD3, SCJ1-9xMyc(TRP1), prc1-1, trp1-1(am), his3-∆200, 
ura3-52, lys2-801, leu2-3,-112, MAT not determined 
this work 
YRG182 ∆jem1::kanMX6, prc1-1, trp1-1(am), his3- 200, ura3-52, lys2-801, 
leu2-3,-112, MATa 
this work 
YRG183 ∆scj1::HIS3, prc1-1, trp1-1(am), his3- 200, ura3-52, lys2-801, leu2-3,-
112, MATa 
this work 
YRG190 ∆jem1::kanMX6,  scj1::HIS3, prc1-1, trp1-1(am), his3- 200, ura3-52, 
lys2-801, leu2-3,-112, MATa 
this work 
YRG277 ∆erj5::HIS3, prc1-1, trp1-1(am), his3- 200, ura3-52, lys2-801, leu2-3,-
112, MATa 
this work 
YRG284 6xHA-HRD3, ∆scj1::HIS5, prc1-1, trp1-1 (am), his3- 200,  leu2-3,-112, 
lys2-801, ura3-52, MATa 
this work 
YRG280 6xHA-HRD3, ∆jem1::kanMX6, prc1-1, trp1-1 (am), his3- 200,  leu2-3,-
112, lys2-801, ura3-52, , MATa 
this work 
YRG362 6xHA-hrd3(KR652/653IL), YOS9-myc7xHIS(kanMX6), prc1-1, trp1-1 
(am), his3- 200,  leu2-3,-112, lys2-801, ura3-52, MATa 
this work 
YRG365 6xHA-hrd3(NR645/646II), YOS9-myc7xHIS(kanMX6), prc1-1, trp1-1 
(am), his3- 200,  leu2-3,-112, lys2-801, ura3-52, MATa 
this work 
 
YRG386 SCJ1-9xMyc (TRP1), ∆hrd3::LEU2, prc1-1, trp1-1(am), his3-∆200, 
ura3-52, lys2-801, leu2-3,-112, MATalpha 
this work 
YTX557 ∆hrd3::LEU2, Der1-13xmyc (TRP), prc1-1, trp1-1(am), his3-∆200, 
ura3-52, lys2-801, leu2-3,-112, MATa 
this work 
YTX485 HRD1-3xHA (TRP1), ∆hrd3::LEU2, prc1-1, trp1-1(am), his3-∆200, 
ura3-52, lys2-801, leu2-3,-112, MATalpha 
this work 
YTX1145 ∆scj1::HISMX6, CPY*-3xHA (kanMX6), trp1-1(am), his3-∆200, ura3-
52, lys2-801, leu2-3,-112, MAT not determined 
this work 
YTX140 prc1-1, trp1-1(am), his3- 200, ura3-52, lys2-801, leu2-3,-112, MATa Biederer et al., 
1997 
YTX365 CPY*-3xHA (kanMX6), trp1-1(am), his3-∆200, ura3-52, lys2-801, leu2-
3,-112, MAT not determined 
this work 
YTX1213 URA3:6xMyc-Hmg2, ∆jem1::kanMX6, prc1-1, trp1-1(am), his3-∆200, 
ura3-52, lys2-801, leu2-3,-112, MATa 
this work 
YTX1214 URA3:6xMyc-Hmg2, ∆scj1::HIS3, prc1-1, trp1-1(am), his3-∆200, ura3-
52, lys2-801, leu2-3,-112, MATalpha 
this work 
YMM072 ∆hrd3::LEU2, ∆der1::HIS3, prc1-1, trp1-1(am), his3-∆200, ura3-52, 
lys2-801, leu2-3,-112, MAT not determined 
this work 
YMM224 Hrd3 K652I/R653L, prc1-1, trp1-1(am), his3-∆200, ura3-52, lys2-801, 
leu2-3,-112, MATa 
this work 
YMM225 Hrd3 K652I/R653L, CPY*-3xHA (KanMX), trp1-1(am), his3-∆200, 
ura3-52, lys2-801, leu2-3,-112, MATa 
this work 
 
 
Supplementary Table 2 
Name Insert and/or purpose Backbone Resource 
pBM108 CD4 pRS414 Meusser et al., 2004 
pGK1-pBpa 3SUP4-tRNA CUA for pBpa incorporation  Chen, et al., 2007 
pFastBac1™ Baculovirus cloning  Invitrogen 
pRH244 6xMyc-Hmg2 for genomic integration  Hampton et al., 1996 
pFZ029 Hrd3 KR652/653IL pJU301 this work 
pFZ060 Hrd3 KR652/653AA pRS317 this work 
pFZ063 6xHA-Hrd3 (–278 … 2690) pRS316 this work 
pFZ064 6xHA-Hrd3 KR652/653IL (–278 … 2690) pRS316 this work 
pTX191 CPY*-CUP pRS413 this work 
pTX339 PrA*  pRS415 this work 
pWO804 CT* pRS316 Taxis et al., 2003 
pSM101 KWW pRS316 Vashist and Ng, 2004 
pJU301 Hrd3 (-386...2706) pRS317 this work 
pMM075 Der1 (1...706)-13xMyc pRS425-CUP Mehnert et al., 2014 
pMM083 1xHis-Scj1 pRS426-CUP this work 
pMM084 Hrd3 KR652/653IL pRS406 this work 
pMM100 1xHis-Scj1 pRS414-CUP this work 
pMM101 1xHis-Scj1 pRS424-CUP this work 
 
 
